Santander CEO: More U.S. Cost Synergies Uncertain
Santander's CEO said it is too early to say whether there is more room to improve cost synergies in the U.S.
Related stories
AbbVie Says Qulipta Outperformed Topiramate in Phase 3 Trial
AbbVie reported that Qulipta outperformed topiramate in a Phase 3 migraine prevention trial.
L impact | EQUITY | Oct 29, 2026, 10:06 AM UTC
L3Harris Q3 Revenue Reaches $6.1 Billion, Above Estimate
L3Harris reported Q3 revenue of $6.1 billion, versus an IBES estimate of $5.913 billion.
M impact | EQUITY | Oct 29, 2026, 10:05 AM UTC
CRH Announces Share Buyback Program of Up to $6 Billion
CRH announced a new share buyback program of up to $6 billion, expiring at the end of 2030.
M impact | EQUITY | Oct 29, 2026, 10:05 AM UTC
Yirui Technology Says Q3 Revenue Rose 71.9% Year Over Year
M impact | EQUITY | Oct 29, 2026, 10:05 AM UTC
Xcel Energy reports third-quarter revenue of $4.17 billion
M impact | EQUITY | Oct 29, 2026, 10:05 AM UTC
HIVE Digital Technologies Secures $129M Financing for AI GPU Cluster
HIVE announced approximately $129 million in three-year financing to fund a sovereign AI GPU cluster for a previously announced customer contract.
M impact | EQUITY | Oct 29, 2026, 10:05 AM UTC